HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VICTORIA Study Group Selected Research

VICTORIA Study Group Research Topics

Disease

25Heart Failure
03/2024 - 12/2019
4Myocardial Infarction
01/2022 - 12/2019
3Hypotension (Low Blood Pressure)
01/2022 - 01/2020
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2019
2Atrial Fibrillation
01/2021 - 12/2019
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2023
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2023
1Inflammation (Inflammations)
01/2023
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Syncope (Fainting)
01/2020
1Hypertension (High Blood Pressure)
12/2019
1Stroke (Strokes)
12/2019

Drug/Important Bio-Agent (IBA)

25vericiguatIBA
03/2024 - 12/2019
4Brain Natriuretic Peptide (Natrecor)FDA Link
10/2023 - 05/2021
2DiureticsIBA
03/2024 - 01/2020
2pro-brain natriuretic peptide (1-76)IBA
10/2023 - 01/2022
2Soluble Guanylyl CyclaseIBA
01/2023 - 01/2020
2BilirubinIBA
06/2021 - 05/2021
2Hormones (Hormone)IBA
06/2021 - 05/2021
2AlbuminsIBA
06/2021 - 05/2021
2Uric Acid (Urate)IBA
06/2021 - 05/2021
2ChloridesIBA
06/2021 - 05/2021
1Biomarkers (Surrogate Marker)IBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
01/2023
1Transaminases (Aminotransferases)IBA
01/2023
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2021
1Neprilysin (Neutral Endopeptidase)IBA
11/2021
1RivaroxabanIBA
12/2019

Therapy/Procedure

2Therapeutics
01/2023 - 01/2020
1Percutaneous Coronary Intervention
01/2022
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022
1Patient Readmission
12/2019